Dentsply Sirona has announced the appointment of Dr Dorothea Wenzel to its Board of Directors, thus increasing the size of the board from 10 to 11 members. Dr Wenzel has also been appointed as a member of the Audit and Finance Committee.
“On behalf of Dentsply Sirona and the Board of Directors, I am pleased to welcome Dr Wenzel to Dentsply Sirona,” said Eric K. Brandt, chairman of the board. “Dr Wenzel is a highly experienced executive with an impressive strategic, financial, and general management track record in the healthcare sector. Her expertise will enhance and broaden the board’s international perspective as we continue to build and refresh our board. We look forward to working with her to continue to shape the future of Dentsply Sirona and work to realise our vision advancing dentistry to improve oral health worldwide.”
Dr Wenzel served for Merck from June 2004 to August 2021, most recently since 2019 as the executive vice-president and head of the Surface Solutions Business Unit. At Merck, she further held various senior management positions in the Healthcare Division of the company.
Prior to joining Merck, Dr Wenzel held a number of finance and business positions in the healthcare industry at AXA Krankenversicherung and Medvantis Holding and worked for several years as consultant and engagement manager at McKinsey & Company.
Dr Wenzel was also a member of the Staff of the Committee for the Sustainability of the Financing of the Social Security Systems, Federal Ministry of Health, Germany. She holds a doctorate in health economics and a diploma in business and computer sciences from the Technical University of Darmstadt. Dr Wenzel is member of the supervisory board of Fresenius Medical Care, and an independent director on the board of H. Lundbeck A/S.